Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
Headshot

Gina Nellesen

Fellowship Attorney

Redwood City, CA
650-839-5059
nellesen@fr.com
Download vCard

Background

Gina Nellesen is a Patent Fellowship Attorney in Fish & Richardson’s Silicon Valley office.  Ms. Nellesen drafts and prosecutes patents for academic institutions, corporations and emerging companies pursuing life sciences.  She collaborates with scientists to capture new intellectual property and builds patent landscapes to help clients understand the patentable space and areas with freedom-to-operate.  She evaluates intellectual property for due diligence analyses that guide investment decisions.

Ms. Nellesen worked in the chambers of Honorable Ronald M. Whyte, Judge for the U.S. District Court, Northern District of California as a legal extern in 2004.

Prior to law school, Ms. Nellesen researched diabetes and tissue engineering at Scripps Research Institute and University of California, San Diego.  She was a bioinformatics programmer at Incyte during the initial sequencing and annotation of the human genome.

In the laboratory of Dr. James Posakony, she developed protein purification techniques and assessed protein–DNA interactions with affinity electrophoresis.

Personal photo

Education

J.D., Santa Clara University School of Law 2005
Intellectual Property Law Focus
​Vice President, Intellectual Property Law Association​


M.S., University of California, San Diego 1999
Biochemistry and Cell Biology


B.S., University of California, San Diego 1998
Biochemistry and Cell Biology
​Howard Hughes Medical Institute Grant Recipient; Provost’s Honors​

Admissions

  • U.S. Patent and Trademark Office 2002
  • California 2006

Other Distinctions

Selected Publications

Dismissal Demonstrates Need for Clarity on BPCIA Disclosure Steps,” with Jenny Shmuel, Fish Litigation Blog, March 13, 2017.

REMICADE® Cell Powder Trial Postponed While Court Addresses Standing and BPCIA Remedies,” with Jenny Shmuel, Fish Litigation Blog, March 3, 2017.

Mixed Results When New Attribution Standard is Put to the Test with Life Science Divided-Actor Method Claims,” with Tasha Francis and Betsy Flanagan, Fish Litigation Blog, March 3, 2017.

Biosimilar Litigants Dispute Probative Value of Statements Exchanged During the Patent Dance,” with Jenny Shmuel, Fish Litigation Blog, February 27, 2017.

Biosimilar Litigants Square Off Before the Supreme Court,” with Jenny Shmuel and Tasha Francis, Fish Litigation Blog, February 16, 2017.

Biosimilars: What to Expect in 2017,” with Jenny Shmuel and Tasha Francis, Fish Litigation Blog, January 23, 2017.

Patent Challengers Must Show Harm to Appeal Final PTAB Decisions,” with Jenny Shmuel and Tasha Francis, Fish Post-Grant Blog, January 20, 2017.

Biosimilars: Looking Back and Looking Ahead,” with Jenny Shmuel and Tasha Francis, Bloomberg Law: Pharmaceutical Law & Industry Report, January 18, 2017.

The First Amendment Does Not Protect All Off-Label Drug Promotion,” with Terry Mahn, Fish Litigation Blog (December 23, 2016).

US Solicitor Sides With Sandoz In Biosimilar Case,” with Elizabeth Flanagan, Law360 (December 20, 2016).

Solicitor General Claims Error in Federal Circuit’s Sandoz Holding,” with Elizabeth Flanagan, Fish Litigation Blog (December 14, 2016).

Amgen Opposes Apotex’s Petition for Certiorari,” with Jenny Shmuel and Tasha Francis, Fish Litigation Blog (November 18, 2016).

Amgen Crystallizes Disagreement in Appeal of Discovery Row,” with Jenny Shmuel and Tasha Francis, Fish Litigation Blog (November 17, 2016).

Hospira Fires Back in Appeal of BPCIA Discovery Dispute,” with Jenny Shmuel, Fish Litigation Blog (October 31, 2016).

Mylan and the Biosimilars Council Urge Supreme Court to Overturn Amgen v. Apotex,” with Tasha Francis and Jenny Shmuel, Fish Litigation Blog (October 21, 2016).

Remedy to Incentivize Innovation as In Vitro Diagnostics Face Patent-Eligibility Challenges and Added Regulatory Scrutiny,” with Terry Mahn Fish Patent Blog (June 30, 2016).

Supreme Court Denies Petition to Review Expanded Theory of Joint Infringement,” with Teresa A. Lavoie, Ph.D. Fish Litigation Blog (May 2, 2016).

Mohr, J. and Freschi, G., “The Positive Side of Negative Disclaimers,” Biopharm Int. Jun;(20):36-39 (2007).

Freschi, G., Navigating the Research Exemption’s Safe Harbor: Supreme Court to Clarify Scope–Implications for Stem Cell Research in California,” 21 Santa Clara Computer & High Tech. L.J. 855-899 (2005).

Barolo, S., Walker, R.G., Polyanovsky, A.D., Freschi, G., Keil, T., Posakony, J.W., A Notch-Independent Activity of Suppressor of Hairless is Required for Normal Mechanoreceptor Physiology,” 103 Cell 957-969 (2000). Work involved aligning DNA sequences across species using computational biology software to show the evolutionary conservation of transcription factor binding domains.

Lai, E., Bodner, R., Kavaler, J., Freschi, G., Posakony, J.W., Antagonism of Notch Signaling Activity by Members of a Novel Protein Family Encoded by the Bearded and Enhancer of Split Gene Complexes,” 127 Development 291-306 (2000).

Bradley, L.M., Harbertson, J., Freschi, G., Kondrack, R., Linton, P.J., Regulation of the Development and Function of Memory CD4 Subsets,” 21 Immunol. Res. 149-158 (2000).

Carver, L., Freschi, G., Posakony, J.W., “In Vitro Analysis of the Su(H) Paired Site (SPS) Upstream of the E(spl)m4 Gene,” Proceedings of the Drosophila Research Conference, Seattle, WA (1999).

Lai, E., Bodner, R., Freschi, G., Kavaler, J., Posakony, J.W., “A Novel Gene Family and its Role in Notch Signaling,” Proceedings of the Neurobiology of Drosophila Meeting, Cold Spring Harbor, NY (1999).

What's trending with Gina

Filter by
Fish Litigation Blog
March 13, 2017
Dismissal Demonstrates Need for Clarity on BPCIA Disclosure Steps
Dismissal Demonstrates Need for Clarity on BPCIA Disclosure Steps
Authors: Gina Nellesen, Jenny Shmuel, Ph.D.
IP Litigation
Fish Litigation Blog
March 3, 2017
REMICADE® Cell Powder Trial Postponed While Court Addresses Standing and BPCIA Remedies
REMICADE® Cell Powder Trial Postponed While Court Addresses Standing and BPCIA Remedies
Authors: Gina Nellesen, Jenny Shmuel, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
March 3, 2017
Mixed Results When New Attribution Standard is Put to the Test with Life Science Divided-Actor Method Claims
Webinar: Patentability of Software After Alice
Authors: Gina Nellesen, Elizabeth M. Flanagan, Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
February 27, 2017
Biosimilar Litigants Dispute Probative Value of Statements Exchanged During the Patent Dance
Biosimilar Litigants Dispute Probative Value of Statements Exchanged During the Patent Dance
Authors: Gina Nellesen, Jenny Shmuel, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
February 16, 2017
Biosimilar Litigants Square Off Before the Supreme Court
Biosimilar Litigants Square Off Before the Supreme Court
Authors: Gina Nellesen, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
January 23, 2017
Biosimilars: What to Expect in 2017
Biosimilars: What to Expect in 2017
Authors: Gina Nellesen, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
Federal Circuit
Life Sciences
News
January 20, 2017
"Biosimilars: Looking Back and Looking Ahead" in Bloomberg Law
Articles
Fish Litigation Blog
December 23, 2016
The First Amendment Does Not Protect All Off-Label Drug Promotion
The First Amendment Does Not Protect All Off-Label Drug Promotion
Authors: Gina Nellesen, Terry G. Mahn
Life Sciences
News
December 21, 2016
"US Solicitor Sides With Sandoz In Biosimilar Case" Law360 article
Media Mention
Articles
Fish Litigation Blog
December 14, 2016
Solicitor General Claims Error in Federal Circuit’s Sandoz Holding
Solicitor General Claims Error in Federal Circuit’s <em>Sandoz</em> Holding
Authors: Gina Nellesen, Elizabeth M. Flanagan
IP Litigation
Federal Circuit
Life Sciences
Fish Litigation Blog
November 18, 2016
Amgen Opposes Apotex’s Petition for Certiorari
Amgen Opposes Apotex’s Petition for Certiorari
Authors: Gina Nellesen, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
November 17, 2016
Amgen Crystallizes Disagreement in Appeal of Discovery Row
Amgen Crystallizes Disagreement in Appeal of Discovery Row
Authors: Gina Nellesen, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
load more topics